artenimol has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Wu, R; Zhang, Q; Zheng, S | 1 |
| Jin, Z; Li, Y; Wang, H; Wang, Y; Xiao, X; Yang, J; Yue, F; Zhang, Y; Zhou, Q; Zhou, S | 1 |
| Blaes, J; Dong, Z; Green, E; Hertenstein, A; Jugold, M; Lemke, D; Löw, S; Ott, M; Platten, M; Pledl, HW; Sahm, F; Steffen, AC; Weiler, M; Wick, W; Winkler, F; Zorn, M | 1 |
3 other study(ies) available for artenimol and Disease Exacerbation
| Article | Year |
|---|---|
Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
Topics: Artemisinins; Biomarkers, Tumor; Calcium Channels; Calcium-Binding Proteins; Cation Transport Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2022 |
Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling.
Topics: Animals; Apoptosis; Artemisinins; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Progression; Drug Evaluation, Preclinical; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Network Pharmacology; Protein Interaction Maps; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy.
Topics: Animals; Antimalarials; Artemisinins; Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Mice; Mice, Nude; Oxidative Stress; Physical Conditioning, Animal; Reactive Oxygen Species; Temozolomide | 2016 |